Ankit Kansagra, MD, UT Southwestern Medical Center, Dallas, TX, outlines the real-world treatment patterns and outcomes of patients with functional high-risk multiple myeloma. In this retrospective study, Dr Kansagra indicates that half of functional high-risk patients recieved stem cell transplantation in second line. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.

свернуть